Running the US Food and Drug Administration is nothing new for Robert Califf, who took the reins of the agency in February 2022. A cardiologist by trade, Califf also ran the agency in the final year of the Obama administration. But, he noted during a recent fireside chat hosted by the Alliance for a Stronger FDA, that was a more “genteel” time.
In reprising his role as commissioner, not only has Califf had to grapple with a global pandemic, but a more hostile political environment emblematic of a divided country.